The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently organized a session in collaboration with the Embassy of India at Romania to explore and boost the pharmaceutical trade opportunities between India and Romania. The session, titled “India-Romania Pharma Business Opportunities,” aimed to facilitate discussions and B2B interactions to strengthen the trade relations between the two countries. Dr. Manoj Kumar Mohapatra, the Ambassador of India to Romania, highlighted the significance of the pharmaceutical sector in enhancing bilateral trade and shared insights on the strengths of the Indian pharma industry. The session also featured presentations by industry experts from Romania, including discussions on guidelines for Medicinal Food Supplements and the potential for generic medicines in the Romanian market.
With the participation of around 15 companies from Romania and 125 companies from India, the B2B sessions organized by Pharmexcil provided a platform for networking and exploring potential collaborations. The pharmaceutical industry in Romania has been witnessing significant growth, driven by factors such as an aging population and increasing healthcare needs. The sector comprises both local and multinational companies, with a strong focus on research and development. The National Agency for Medicines and Medical Devices of Romania (NAMMDR) serves as the regulatory authority overseeing the pharmaceutical sector in the country, ensuring compliance with quality and safety standards.
Government policies in Romania aim to promote the use of generic drugs to reduce healthcare costs and improve access to essential medicines. This presents an opportunity for Indian pharmaceutical companies to collaborate with Romanian counterparts for research, development, and licensing of drugs tailored to the European market. In 2024, India’s exports of pharmaceutical products to Romania amounted to USD 33.45 million, indicating a growing trade relationship between the two countries. The exports include a range of pharmaceutical goods such as medicaments and blood fractions, reflecting the diversity of products being traded.
Looking ahead, there is immense potential for further expansion of the pharmaceutical trade between India and Romania. Both countries are exploring new avenues for collaboration and partnership to enhance their trade relations. Pharmexcil’s invitation to Romania to participate in iPHEX 2025, scheduled to be held in New Delhi, signifies a commitment to fostering stronger ties and facilitating business interactions between the pharmaceutical industries of the two nations. The session not only served as a platform for knowledge exchange but also as a catalyst for future collaborations and partnerships in the pharmaceutical sector.
In conclusion, the session organized by Pharmexcil provided valuable insights into the evolving landscape of pharmaceutical trade between India and Romania. With a focus on leveraging strengths, promoting innovation, and exploring new avenues for collaboration, both countries have the opportunity to further enhance their trade relations in the pharmaceutical sector. By fostering partnerships, sharing expertise, and aligning regulatory frameworks, India and Romania can work towards a mutually beneficial trade relationship that drives growth and innovation in the pharmaceutical industry.
Key Takeaways:
– The pharmaceutical trade between India and Romania is growing, with opportunities for collaboration in research, development, and licensing of drugs.
– Government policies in Romania promote the use of generic drugs to reduce healthcare costs and improve access to essential medicines.
– Platforms like the session organized by Pharmexcil play a crucial role in facilitating B2B interactions and strengthening trade relations in the pharmaceutical sector.
Tags: regulatory
Read more on pharmabiz.com